A New Role for Glutathione:  Protection of Vitamin B12 from Depletion by Xenobiotics

William P. Watson,* Tony Munter, and Bernard T. Golding*
Syngenta Central Toxicology Laboratory, Alderley Park, Cheshire, SK10 4TJ, United Kingdom, and School of Natural SciencesChemistry, Bedson Building, University of Newcastle upon Tyne, Newcastle upon Tyne, NE1 7RU, United Kingdom
Chem. Res. Toxicol., 2004, 17 (12), pp 1562–1567
DOI: 10.1021/tx0497898
Publication Date (Web): November 17, 2004
Copyright © 2004 American Chemical Society
*

 To whom correspondence should be addressed. E-mail: william.watson@syngenta.com or b.t.golding@ncl.ac.uk.

,

 Syngenta Central Toxicology Laboratory.

,

 University of Newcastle upon Tyne.

Abstract

Abstract Image

NADPH in microsomes reduces the hydroxocob(III)alamin form of vitamin B12 to cob(II)alamin and the supernucleophilic cob(I)alamin, which are both highly reactive toward xenobiotic epoxides formed by mammalian metabolism of dienes such as the industrially important chemicals chloroprene and 1,3-butadiene. With styrene, the metabolically formed styrene oxide is reactive toward cob(I)alamin but not cob(II)alamin. Such reactions in humans could lead to vitamin B12 deficiency, which is implicated in pernicious anemia, cancer, and degenerative diseases. However, glutathione inhibits the reduction of hydroxocob(III)alamin by formation of the 1:1 complex glutathionylcobalamin. This blocks reactions of the cobalamins with metabolically formed epoxides. The interaction between glutathione and vitamin B12 could protect against diseases related to vitamin B12 depletion.

Tools

History

  • Published In Issue December 20, 2004
  • Received August 4, 2004

Recommend & Share

Related Content

Other ACS content by these authors: